Blue Matter Blog
May 3, 2024
Summary This spring, Blue Matter’s London team hosted the third meeting of the UK Biotech Club for C-suite leaders representing 20 London-based biotech companies. The leaders shared their perspectives on the outlook for the UK’s biotech sector and keys to succeed in a competitive industry. Conversation focused on how managing stakeholder relations, particularly with investors …
July 20, 2023
Summary This summer, Blue Matter’s London team hosted the second meeting of the UK Biotech Club, inviting C-suite leaders and directors from 15 biotech companies in the Cambridge biotech sector. These companies are developing diagnostics, vaccines, discovery platforms, small molecule therapeutics and biologics, covering all lifecycle stages from discovery through to commercialization. Attendees discussed challenges, …
January 9, 2023
The University of Oxford is regularly ranked as the best in the world. However, it is widely accepted that the associated biotech landscape is not as advanced as comparable locations in the US. For example, Boston is well-established as an innovation hub while Oxford remains nascent. Nothing is permanent, though, and in a dynamic space …